Stay updated on Pembrolizumab for Metastatic Anal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedRevision tag updated to v3.5.0, replacing the previous v3.4.3 tag.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; no visible changes to study details or user-facing content.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision: v3.4.2 was added and the government funding notice along with Revision: v3.4.1 were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check72 days agoChange DetectedAdded a site-wide notice about the government funding lapse and NIH Clinical Center operating status with links for more information. Updated the page footer from Revision: v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check80 days agoChange DetectedAdded a glossary option, updated metadata labels (Last Update Submitted that Met QC Criteria, Revision: v3.4.0), and adjusted capitalization (No FEAR Act data); these cosmetic changes do not affect core study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab for Metastatic Anal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page.